Page last updated: 2024-08-25

7-hydroxystaurosporine and Experimental Neoplasms

7-hydroxystaurosporine has been researched along with Experimental Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aslanian, AS; Lees, JA; Reinhardt, HC; Yaffe, MB1
Akinaga, S; Gomi, K; Nomura, K; Okabe, M1
Saijo, N1
Akinaga, S; Akiyama, T; Fuse, E; Kobayashi, H; Kobayashi, S; Kurata, N; Kuwabara, T; Tanii, H; Yamaguchi, K1
Abe, S; Akinaga, S; Akiyama, T; Furukawa, T; Kitajima, M; Kubota, T; Kumai, K; Otani, Y; Watanabe, M1
Akinaga, S; Gomi, K; Morimoto, M; Okabe, M; Tamaoki, T1

Reviews

1 review(s) available for 7-hydroxystaurosporine and Experimental Neoplasms

ArticleYear
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Chest, 1998, Volume: 113, Issue:1 Suppl

    Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

1998

Other Studies

5 other study(ies) available for 7-hydroxystaurosporine and Experimental Neoplasms

ArticleYear
p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
    Cancer cell, 2007, Volume: 11, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Bone Neoplasms; cdc25 Phosphatases; Cell Cycle Proteins; Cell Division; Cell Survival; Cells, Cultured; Cisplatin; DNA Damage; DNA Repair; DNA-Binding Proteins; Doxorubicin; G2 Phase; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, Knockout; Mice, Nude; Mitosis; Neoplasms, Experimental; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Protein Kinases; Protein Serine-Threonine Kinases; S Phase; Signal Transduction; Staurosporine; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ultraviolet Rays

2007
Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
    Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:3

    Topics: Alkaloids; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Division; Drug Synergism; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Mice, Nude; Mitomycin; Neoplasm Transplantation; Neoplasms, Experimental; Protein Kinase C; Staurosporine; Tumor Cells, Cultured

1993
Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:1

    Topics: Alkaloids; Animals; Antineoplastic Agents; Dogs; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Pancreatic Neoplasms; Rats; Rats, Sprague-Dawley; Staurosporine; Tissue Distribution; Transplantation, Heterologous

1999
UCN-01 (7-hydoxystaurosporine) inhibits in vivo growth of human cancer cells through selective perturbation of G1 phase checkpoint machinery.
    Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:5

    Topics: Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; CDC2-CDC28 Kinases; Cell Division; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA, Neoplasm; Drug Resistance, Neoplasm; G1 Phase; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Staurosporine; Transplantation, Heterologous

2001
Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models.
    Cancer research, 1991, Sep-15, Volume: 51, Issue:18

    Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Division; Down-Regulation; ErbB Receptors; Humans; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Oncogenes; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1991